Prevalence of Anti-Tuberculosis Drug Resistance in Foreign-Born Tuberculosis Cases in the U.S. and in Their Countries of Origin

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Taylor, Allison B ^a   Kurbatova, Ekaterina V ^a   Cegielski, J Peter ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CORRELATION ANALYSIS; GEOGRAPHIC ORIGIN; HUMAN; LINEAR REGRESSION ANALYSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; POPULATION RESEARCH; PREDICTION; PREVALENCE; TUBERCULOSIS; UNITED STATES;

ANTITUBERCULAR AGENTS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); DRUG RESISTANCE, BACTERIAL; EMIGRANTS AND IMMIGRANTS; EPIDEMIOLOGICAL MONITORING; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RIFAMPIN; TUBERCULOSIS; UNITED STATES;

EID: 84868695298     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049355     Document Type: Article

References (14)

1. CDC Reported Tuberculosis in the United States, 2009 (2010) U.S. Department of Health and Human Services, CDC. Atlanta, GA, United States of America.
2. Cain K, Benoit S, Winston C, Mac Kenzie W, (2008) Tuberculosis among foreign-born persons in the United States. JAMA (Chicago, Ill) 300: 405-412.
3. World Health Organization (2010) Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Geneva, Switzerland.
4. WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance (1997) Anti-Tuberculosis Drug Resistance in the World. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 1994-1997. Geneva, Switzerland.
5. WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance (2000) Anti-Tuberculosis Drug Resistance in the World- Report No.2, Prevalence and Trends. Geneva, Switzerland.
6. WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance (2004) Anti-tuberculosis drug resistance in the world: third global report. Geneva. Geneva, Switzerland.
7. World Health Organization (2008) Anti-tuberculosis drug resistance in the world: fourth global report. Geneva, Switzerland.
8. World Health Organization (2006) Global Tuberculosis Control. Surveillance, Planning, Financing. WHO Report 2006. Geneva, Switzerland.
9. Bass JB Jr, Farer LS, Hopewell PC, OBrien R, Jacobs RF, et al. (1994) Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention. Am J Respir Crit Care Med 149: 1359-1374.
10. Khan K, Muennig P, Behta M, Zivin J, (2002) Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States. The New England journal of medicine 347: 1850-1859.
11. Campbell PJ, Morlock GP, Sikes RD, Dalton TL, Metchock B, et al. (2011) Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Antimicrob Agents Chemother 55: 2032-2041.
12. Reichman L, Lardizabal A, Hayden C, (2004) Considering the role of four months of rifampin in the treatment of latent tuberculosis infection. American journal of respiratory and critical care medicine 170: 832-835.
13. Granich RM, Moore M, Binkin NJ, McRay E, (2001) Drug-resistant tuberculosis in foreign-born persons from Mexico, the Philippines, and Vietnam-United States, 1993-1997. The international journal of tuberculosis and lung disease 5: 53-58.
14. Moniruzzaman A, Elwood RK, Schulzer M, FitzGerald JM, (2006) Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia. The international journal of tuberculosis and lung disease 10: 844-850.